HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria

A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment

NCT04527328 ·Status: COMPLETED ·Phase: NA

Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function

NCT02678000 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4

NCT03596749 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease

NCT06350123 ·Status: COMPLETED ·Phase: PHASE2

Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure

NCT02511418 ·Status: COMPLETED ·Phase: NA

Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients

NCT01271478 ·Status: COMPLETED ·Phase: PHASE4

A Study of Telitacicept for IgA Nephropathy (TELIGAN)

NCT05799287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease

NCT06071143 ·Status: RECRUITING ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

NCT02044653 ·Status: COMPLETED ·Phase: PHASE2

A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

NCT05951192 ·Status: COMPLETED ·Phase: PHASE4

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

NCT06593392 ·Status: RECRUITING ·Phase: PHASE2

A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis

NCT01554982 ·Status: COMPLETED ·Phase: PHASE3

Clinical Pharmacology Study of TS-143 in Nondialysis and Hemodialysis Patients with Chronic Kidney Disease

NCT03581071 ·Status: COMPLETED ·Phase: PHASE1

Colchicine in Chronic Kidney Disease Patients

NCT06998862 ·Status: RECRUITING ·Phase: PHASE3

Randomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental Glomerulosclerosis

NCT01613118 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Conditions

NCT04906798 ·Status: UNKNOWN ·Phase: PHASE1

Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers

NCT05089279 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects

NCT05602129 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy of Pentoxifylline on Chronic Kidney Disease

NCT00155246 ·Status: COMPLETED ·Phase: PHASE4

A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)

NCT02912533 ·Status: COMPLETED ·Phase: PHASE3

Study of Telitacicept in Patients With Refractory IgA Nephropathy

NCT05596708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3

Clinical Validation Study for Optimization of Anemia MAnagement in Hemodialysis Patients With End Stage Kidney Disease Using the Dialysis Anemia TReatmenT Model

NCT05936021 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

NCT03710291 ·Status: TERMINATED ·Phase: PHASE3

Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia

NCT04408820 ·Status: COMPLETED

Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function

NCT02508506 ·Status: COMPLETED ·Phase: PHASE1